ليست عنوان مقالات لاتين Neurological aspects of hair growth Neurostimulation as a Putative Method for the Treatment of Drug-resistant Epilepsy in Patient and Animal Models of Epilepsy

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Neurological aspects of hair growth

2

Neurological aspects of multiple myeloma and related disorders

3

Neurological aspects of spinal-cord repair: promises and challenges

4

Neurological aspects of the Angelman syndrome

5

Neurological bases for balance–anxiety links

6

Neurological bases of behavioral development in infancy

7

Neurological basis of skill learning

8

Neurological cases for experts only!

9

Neurological comorbidity affects prognosis in left ventricular hypertrabeculation/noncompaction

10

Neurological Complication of Infective Endocarditis Misdiagnosing with Multiple Sclerosis: A Case Report

11

Neurological complications and Japanese encephalitis vaccination

12

Neurological Complications Following Percutaneous Coronary Interventions (A Report from the 2000–2001 New York State Angioplasty Registry)

13

Neurological complications in heparin-induced thrombocytopenia

14

Neurological complications in renal failure: a review

15

Neurological complications in β-thalassemia

16

Neurological Complications of Corona Virus: A Mini-Review

17

Neurological complications of HIV infection

18

Neurological complications of HIV infection

19

Neurological Compromise Associated With COVID-19 Is Broader Than Anticipated Comment on “COVID-19 Pandemic and Neurological Disease: A Critical Review of the Existing Literature”

20

Neurological Crises after Discontinuation of Nitisinone (NTBC) Treatment in 3 Cases of Tyrosinemia

21

Neurological deficit as the first manifestation of vesical transitional cell carcinoma

22

neurological deficit following combined spinal-Epidural Anesthesia for knee arthroplasty

23

Neurological Disorders and Oxidative Toxic Stress: A Role of Metal Nanoparticles

24

Neurological disorders and the structure of human consciousness

25

Neurological disorders caused by inherited ion-channel mutations

26

Neurological Disorders due to Recurrent Hypoglycemia

27

Neurological disturbances due to filgrastim

28

Neurological Dysfunction in Elderly Patients Undergoing Coronary Artery Bypass Operation

29

Neurological effects of high-dose idebenone in patients with Friedreichʹs ataxia: a randomised, placebo-controlled trial

30

Neurological efficacy of stavudine, zidovudine, and lamivudine

31

Neurological efficacy of stavudine, zidovudine, and lamivudine

32

Neurological evaluation and intelligence testing in the child with operated congenital heart disease

33

Neurological Examination and Hearing Assessment of Premature Infants with Gestational Age of Less Than 32 Weeks at Follow-up

34

Neurological examination findings to predict limitations in mobility and falls in older persons without a history of neurological disease

35

Neurological finding of Mitochondrial Syndromes (MERRF and MELAS)

36

Neurological findings and outcome in adult cerebral malaria

37

Neurological Functions of CEO Investment based on Varimax Analysis and Rotated Matrix in Q Typology

38

Neurological gait disorders in elderly people: clinical approach and classification

39

NEUROLOGICAL IMPROVEMENT AFTER CERVICAL TRACTION IN PATIENTS WITH CERVICAL SPINE INJURY

40

Neurological infection

41

Neurological infection in The Lancet Neurology

42

Neurological infections: clinical advances and emerging threats

43

Neurological infections: clinical advances, global threats

44

Neurological Involvement of Patients with COVID-19: Proposed Neuroinvasive Mechanisms and Management

45

Neurological manifestation of coeliac disease with particular emphasis on gluten ataxia and immunological injury: a review article

46

Neurological Manifestation of COVID-19: A Literature Review

47

Neurological Manifestations and Risk Factors of HTLV-1 Infection in the Middle East Region and Iran: A Comprehensive Review of 137 Articles of the Last 23 Years

48

Neurological Manifestations and their Correlated Factors in COVID-19 Patients; a Cross-Sectional Study

49

Neurological Manifestations as Presenting Feature of Osteopetrosis in Children; A Review of 11 Cases

50

Neurological Manifestations in Critically Ill COVID-19 Patients

51

Neurological manifestations in patients with antiphospholipid syndrome.

52

NEUROLOGICAL MANIFESTATIONS OF ALLGROVE SYNDROME

53

Neurological Manifestations of an Old Disease: A Case Report

54

Neurological manifestations of Behçet’s disease

55

Neurological Manifestations of Celiac Disease

56

Neurological manifestations of dengue infection Original Research Article

57

Neurological manifestations of Ehlers-Danlos syndrome(s): A review.

58

Neurological manifestations of Hansenʹs disease and their management

59

Neurological Manifestations of Hospitalized COVID-19-Infected Patients: A Single-Center Cohort Study

60

Neurological manifestations of knockout mice with β-galactosidase deficiency

61

Neurological Manifestations of Patients Hospitalized with Coronavirus Disease 2019 in Babol, Iran

62

Neurological Manifestations of Renal Diseases in Children in Qazvin/ Iran

63

NEUROLOGICAL MANIFESTATIONS OF WILSONʹS DISEASE

64

Neurological manifestations, diagnosis, and treatment of celiac disease: A comprehensive review

65

Neurological Measurement of Human Trust in Automation Using Electroencephalogram

66

Neurological mechanisms of green tea polyphenols in Alzheimerʹs and Parkinsonʹs diseases

67

Neurological melioidosis

68

Neurological Monitoring and Off-Pump Surgery in a Very High-Risk Stroke Patient

69

Neurological outcome and S100 after coronary artery bypass grafting and abdominal aortic surgery

70

Neurological outcome following delayed fixation of unstable thoracolumbar spinal injuries with short segment posterior fixation

71

Neurological outcome of normothermic versus hypothermic cardiopulmonary bypass in simple congenital heart diseases

72

Neurological outcomes in coronary surgery: independent effect of avoiding cardiopulmonary bypass

73

Neurological presentation of Griscelli syndrome: Obstructive hydrocephalus without haematological abnormalities or organomegaly

74

Neurological presentation of three patients with 22q11 deletion (CATCH 22 syndrome)

75

Neurological presentations of nutritional vitamin B12 deficiency in 42 breastfed infants in Southeast Turkey

76

Neurological prognosis correlated with variations over time in the number of subependymal nodules in tuberous sclerosis

77

Neurological recovery in 80 cases of rapid stereotactic evacuation and local fibrinolysis in spontaneous hematomas of putamen and thalamus

78

Neurological Rehabilitation of Stroke Patients by Means of a Robotically Assisted Brain Controlled Interface

79

Neurological sequelae following a high voltage electrical burn

80

Neurological sequelae in children born after in-vitro fertilisation: a population-based study

81

Neurological sequelae in in-vitro fertilisation babies

82

Neurological sequelae in in-vitro fertilisation babies

83

Neurological sequelae in in-vitro fertilisation babies

84

Neurological sequelae in in-vitro fertilisation babies

85

Neurological sequelae of cerebral malaria

86

Neurological sequelae of cerebral malaria

87

Neurological Sequels and Their Causes in Patients Hospitalized in the Toxicology Intensive Care Unit of Bahraloo Hospital, Tehran, Iran

88

Neurological soft signs and response to risperidone in chronic schizophrenia

89

Neurological soft signs in bipolar I disorder patients

90

Neurological soft signs in schizophrenia: Are they related to negative or positive symptoms, neuropsychological performance, and violence?

91

Neurological soft signs, clinical symptoms and treatment reactivity in patients suffering from first episode schizophrenia

92

Neurological Soft Signs: A Further Step in the Diagnosis of Bipolar-I Disorder

93

Neurological Soft Signs: A Further Step in the Diagnosis of Bipolar-I Disorder?

94

Neurological Study of Radial Nerve Conduction During Endoscopic Radial Artery Harvesting:An Intra‐Operative Evaluation

95

Neurological Symptom in a Case of Adrenal Insufficiency

96

Neurological Symptoms as the First Presentation of Transitional Cell Carcinoma of Renal Pelvis

97

Neurological Wilson Disease in children: a three years experience from Multan

98

Neurologists are not immune

99

Neurologists determine the effect of migraine on quality of life

100

Neurologists give better stroke care

101

Neurologists say Florida woman is very unlikely to recover

102

103

Neurology elective at The Royal London Hospital

104

Neurology in sub-Saharan Africa—WHO cares?

105

Neurology of paediatric infectious diseases and immunodeficiency

106

Neurology of Touretteʹs syndrome (TS) TS as a developmental dopamine disorder: a hypothesis

107

Neurology of widely embedded free will

108

Neurology on the global health agenda

109

Neurology residency training in Europe: an Italian perspective

110

Neurology starters: simple to sublime

111

Neurology training around the world

112

Neurolymphomatosis as a single sign of tumor recurrence in a patient with diffuse large B-cell lymphoma of the testis

113

Neurolymphomatosis in Recrudescent Diffuse Large B-cell Lymphoma

114

Neurolymphomatosis of brachial plexus: A rare clinical presentation and the role of 18F-FDG PET/CT

115

Neuromagnetic activity in alpha and beta bands reflect learning-induced increases in coordinative stability

116

Neuromagnetic alpha suppression during an auditory Sternberg task: Evidence for a serial, self-terminating search of short-term memory

117

Neuromagnetic correlates of intra- and extra-dimensional set-shifting

118

Neuromagnetic effects on Anomalous Cognitive Experiences: A Critical Appraisal of the Evidence for Induced Sensed-presence and Haunt-type Experiences

119

Neuromagnetic imaging of cortical oscillations accompanying tactile stimulation

120

Neuromagnetic responses to vowels vs. tones reveal hemispheric lateralization

121

Neuromagnetic source localization of auditory evoked fields and intracerebral evoked potentials: a comparison of data in the same patients

122

Neuromarketing: beyond branding

123

Neuromarketing: Where marketing and neuroscience meet

124

Neuromedin B receptor antagonist suppresses tumor angiogenesis and tumor growth in vitro and in vivo

125

Neuromedin U is overexpressed in pancreatic cancer and increases invasiveness via the hepatocyte growth factor c-Met pathway

126

Neuromelanins in various regions of human brain are associated with native and oxidized isoprenoid lipids

127

Neurometabolic Diagnosis in Children who referred as Neurodevelopmental Delay (A Practical Criteria, in Iranian Pediatric Patients)

128

Neurometabolic Registry Site in Iran

129

130

Neuro-models for discharge air temperature system

131

Neuromodulation of parietal and motor activity affects motor planning and execution

132

Neuromodulation therapy does not influence blood flow distribution or left-ventricular dynamics during acute myocardial ischemia

133

Neuromodulation: acetylcholine and memory consolidation

134

Neuromodulation: An Overview

135

Neuromodulations of the Intractable Neurologic Symptoms

136

Neuromodulatory control of hippocampal function: towards a model of Alzheimer’s disease

137

Neuromodulatory role of Bacopa monnieri on oxidative stress induced by postnatal exposure to decabromodiphenyl ether (PBDE -209) in neonate and young female mice

138

Neuromodulatory unpaired median neurons in the New Zealand tree weta, Hemideina femorata

139

Neuromolecularware and its application to pattern recognition

140

Neuromonitoring and neurocognitive outcome in off-pump versus conventional coronary bypass operation

141

Neuromonitoring for awareness during surgery

142

Neuromonitoring of the external branch of the superior laryngeal nerve during thyroid surgery

143

Neuro-monte carlo solution of electrostatic problems

144

Neuromorbidity in preterm twins in relation to chorionicity and discordant birth weight

145

Neuromorphic implementation of orientation hypercolumns

146

Neuromorphic Synapses for Artificial Dendrites

147

Neuromotor control in stuttering: Speech, orofacial nonspeech, and finger movements

148

Neuromotor Issues in Human Performance: Introduction

149

Neuromotor Issues in the Learning and Control of Golf Skill

150

Neuro-mucormycosis: Lessons from COVID-19-associated cases

151

Neuromuscular Adjustments of the Quadriceps Muscle After Eccentric Resistance and Concentric Resistance Training

152

Neuromuscular and balance responses to flywheel inertial versus weight training in older persons

153

Neuromuscular and Blood Lactate Response After a Motocross Training Session in Amateur Riders

154

Neuromuscular and Metabolic Responses to Three Different Resistance Exercise Methods

155

Neuromuscular and psychomotor abnormalities in patients with schizophrenia and their first-degree relatives

156

Neuromuscular and spatial constraints on bimanual hand-held pendulum oscillations: Dissociation or combination?

157

Neuromuscular Blockade After Ingestion of Tree Tobacco (Nicotiana glauca), ,

158

Neuromuscular blockade as part of an anaesthetic protocol for cataract surgery in an alpaca

159

Neuromuscular Blockade, Bariatric Surgeon Satisfaction, and Quality of Patient Recovery

160

Neuromuscular Blocking Agent Use in Acute Respiratory Distress Syndrome: Which Variable is Important?

161

NEUROMUSCULAR BLOCKING AGENTS IN THE INTENSIVE CARE UNITS

162

Neuromuscular changes in a rat model of colitis

163

Neuromuscular Characteristics of Endurance- and Power-Trained Athletes

164

Neuromuscular consequences of prolonged hunger strike: an electrophysiological study

165

Neuromuscular Control and Coordination During Cycling

166

Neuromuscular control model of the arm including feedback and feedforward components

167

Neuromuscular disease laboratory

168

Neuromuscular diseases: therapeutic advances

169

Neuromuscular disorder in response to anterior cruciate ligament creep

170

Neuromuscular disorders in critical illness

171

Neuromuscular disorders: molecular and therapeutic insights

172

Neuromuscular disorders: orphan diseases deserve attention

173

Neuromuscular disorders: therapeutic advances

174

Neuromuscular dysfunction associated with delayed weaning from mechanical ventilation in patients with respiratory failure

175

NEUROMUSCULAR EFFECTS OF CISATRACURIUM IN MORBIDLY OBESE PATIENTS

176

Neuromuscular Electric Stimulation Versus Traditional Treatment on Harris Hip Score in Cases of Avascular Necrosis of Femoral Head After Kidney Transplantation

177

NEUROMUSCULAR ELECTRICAL STIMULATION OF MEDIUM an‎d LOW FREQUENCY ON THE QUADRICEPS FEMORIS

178

Neuromuscular Electrical Stimulation of the Cricothyroid Muscle in Patients With Suspected Superior Laryngeal Nerve Weakness

179

Neuromuscular excitability properties in myotonic dystrophy type 1

180

Neuromuscular function and bone density as independent predictors of fracture in older women: A 10-year longitudinal study

181

Neuromuscular implications in left ventricular hypertrabeculation/noncompaction

182

Neuromuscular mechanisms and anthropometric modifications in the initial stages of independent gait

183

Neuromuscular Mechanisms of Primary Peristalsis

184

Neuromuscular neutral zones response to cyclic lumbar flexion

185

Neuromuscular neutral zones response to static lumbar flexion: Muscular stability compensator

186

Neuromuscular neutral zones sensitivity to lumbar displacement rate

187

Neuromuscular objectives of the human masticatory apparatus during static biting

188

Neuromuscular Problems in the Patients With COVID-19: A Review Study

189

Neuromuscular recovery in ACL reconstruction with Bone-Tendon-Patellar-Bone and Semitendinosus-Gracilis autograft

190

Neuromuscular Retraining versus BTX-A Injection in Subjects with Chronic Facial Nerve Palsy, A Clinical Trial

191

Neuromuscular symptoms and dysfunction in subclinical hypothyroid patients: beneficial effect of L-T4 replacement therapy

192

Neuromuscular variables affecting the magnitude of force loss after eccentric exercise

193

Neuromuscular versus behavioural influences on reaching performance in young and elderly women

194

Neuromyelitis optica — Devicʹs syndrome, update

195

Neuromyelitis Optica and Nucleotide Variations of Aquaporin-4 Gene

196

Neuromyelitis optica in a patient with an early onset demyelinating episode: Clinical and autoantibody findings

197

Neuromyelitis optica in a pregnant woman with systemic lupus erythematous: A case report

198

Neuromyelitis Optica in Children: A Rare Entity

199

Neuromyelitis optica spectrum disease characteristics in Isfahan, Iran: A cross‑sectional study

200

Neuromyelitis optica: what it is and what it might be

201

202

Neuromyotonia, myocloni, sensory neuropathy and cerebellar symptoms in a patient with antibodies to neuronal nucleoproteins (anti-Hu-antibodies)

203

Neuromythology of Einstein’s brain

204

Neuron Cell Type-specific SNAP-25 Expression Driven by Multiple Regulatory Elements in the Nematode Caenorhabditis elegans

205

Neuron death due to unfolded protein response in gangliosidosis

206

Neuron death in ALS may be due to effects of neighbours

207

Neuron firing in driven nonlinear integrate-and-fire models

208

Neuron loss after coronary artery bypass detected by SPECT estimation of benzodiazepine receptors

209

Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis Review Article

210

Neuron Mathematical Model Representation of Neural Tensor Network for RDF Knowledge Base Completion

211

Neuron Numbers and Volume of the Amygdala in Subjects Diagnosed with Bipolar Disorder or Schizophrenia

212

Neuron source energy on resonance absorption

213

Neuronal activation and plasticity in Schistosoma mansoni infected mice

214

Neuronal activation in response to isoproterenol (Iso) in 6-day-old rat pups

215

Neuronal activity in the basal ganglia and thalamus in patients with dystonia

216

Neuronal and glial cell types revealed by NADPH-diaphorase histochemistry in the retina of a teleost fish, the grass goby (Zosterisessor ophiocephaluSy Perciformes, Gobiidae)

217

Neuronal and glial changes in the brain resulting from explosive blast in an experimental model

218

Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain

219

Neuronal and microglial cathepsins in aging and age-related diseases

220

Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer

221

Neuronal Approach and the Use of KIK-NET Network to Generate Response Spectrum on the Surface

222

Neuronal assemblies: necessity, signature and detectability

223

Neuronal autoantibodies in focal epilepsy with or without mesial temporal sclerosis

224

Neuronal BC1 RNA: Microtubule-dependent Dendritic Delivery

225

Neuronal CDK7 in hippocampus is related to aging and Alzheimer disease

226

Neuronal Cell Death in the Ischemic Spinal Cord: The Effect of Methylprednisolone

227

Neuronal cell death, nerve growth factor and neurotrophic models: 50 years on

228

Neuronal cell protective and antioxidant effects of phenolics obtained from Zanthoxylum piperitum leaf using in vitro model system

229

Neuronal Cell Reconstruction with Umbilical Cord Blood Cells in the Brain Hypoxia-Ischemia

230

Neuronal ceroid lipofuscinosis in a 31-year-old woman presenting as biventricular heart failure with restrictive features

231

Neuronal ceroid-lipofuscinosis: late infantile form or juvenile form?

232

Neuronal Changes in Normal Human Aging and Alzheimerʹs Disease

233

Neuronal circuitries involved in thermoregulation

234

Neuronal codes: reading them and learning how their structure influences network organization

235

Neuronal computers Original Research Article

236

Neuronal connections of the paratrigeminal nucleus: a topographic analysis of neurons projecting to bulbar, pontine and thalamic nuclei related to cardiovascular, respiratory and sensory functions

237

Neuronal contact guidance in magnetically aligned fibrin gels: effect of variation in gel mechano-structural properties

238

Neuronal Control of Metabolism through Nutrient-Dependent Modulation of Tracheal Branching

239

Neuronal correlates of “free will” are associated with regional specialization in the human intrinsic/default network

240

Neuronal Correlates of Colour-Graphemic Synaesthesia: Afmri Study

241

Neuronal correlates of context-related behavior

242

Neuronal Correlates of Obsessions in the Caudate Nucleus

243

Neuronal damage after hypothermic circulatory arrest and retrograde cerebral perfusion in the pig

244

Neuronal damage of the dorsal hippocampus induced by long-term right common carotid artery occlusion in rats

245

Neuronal death in the central nervous system during development

246

Neuronal degeneration and a decrease in laminin-like immunoreactivity is associated with elevated tissue-type plasminogen activator in the rat hippocampus after kainic acid injection

247

Neuronal differentiation modifies the effect of ethanol exposure on voltage-dependent calcium channels in NG 108-15 cells

248

Neuronal differentiation of induced pluripotent stem cells in hybrid polyester scaffolds with heparinized surface

249

Neuronal differentiation of mouse amnion membrane derived stem cells in response to neonatal brain medium

250

Neuronal Differentiation of Mouse Embryonic Stem Cells: Lineage Selection and Forced Differentiation Paradigms

251

Neuronal Differentiation of Rat Hair Follicle Stem Cells: the Involvement of the Neuroprotective Factor Seladin-1 (DHCR24)

252

Neuronal DNA damage correlates with overexpression of interleukin-1β converting enzyme in APPV717F mice

253

Neuronal effects of auditory distraction on visual attention

254

Neuronal Environment: the Brain Homeostasis in Health and Disease: W. Waltz, Humana Press, ISBN 0-89603-882-3, $145.00

255

Neuronal event detection in fMRI time series using iterative deconvolution techniques

256

Neuronal evolution: analysis of regulatory genes in a first-evolved nervous system, the hydra nervous system

257

Neuronal expression of Raf protooncogene in the brain stem of adult guinea pig

258

Neuronal feedback between brain and inner ear for growth of otoliths in fish Original Research Article

259

Neuronal firing activity in the dorsal hippocampus during the auditory discrimination oddball task in awake rats: relation to event-related potential generation

260

Neuronal function in chronic spinal cord injury: Divergence between locomotor and flexion- and H-reflex activity

261

Neuronal injury and death following focal mild brain injury: The role of network excitability and seizure

262

Neuronal Innervation, Intracellular Signal Transduction and Intercellular Coupling: a Model for Syncytial Tissue Responses in the Steady State

263

Neuronal Inputs from the Hypothalamus and Brain Stem to the Medial Preoptic Area of the Ram: Neurochemical Correlates and Comparison to the Ewe

264

Neuronal instability: implications for Rettʹs syndrome

265

Neuronal insulin signal transduction mechanisms in diabetes phenotypes

266

Neuronal intranuclear inclusion disease: neuropathologic study of a case

267

Neuronal kinase stimulation leads to aberrant tau phosphorylation and neurotoxicity

268

Neuronal kinase stimulation leads to aberrant tau phosphorylation and neurotoxicity

269

Neuronal lipofuscinosis

270

Neuronal loss and β-amyloid removal in the amygdala of people with Down syndromesmall star, filled

271

Neuronal loss in the colon of constipated Parkinsonʹs disease patients mimics that in the brain

272

Neuronal MAP2 mRNA: Species-dependent Differential Dendritic Targeting Competence

273

Neuronal maturation and N-acetyl-l-aspartic acid development in human fetal and child brains

274

Neuronal mechanisms mediating drug-induced cognition enhancement: cognitive activity as a necessary intervening variable

275

Neuronal Microtubule-associated Proteins: Insights into Their Structures and Functions

276

Neuronal migrational disorders in children with epilepsy: MRI, interictal SPECT and EEG comparisons

277

Neuronal nicotinic acetylcholine receptor binding affinities of boron-containing nicotine analogues

278

Neuronal nicotinic receptors and epilepsy, from genes to possible therapeutic compounds

279

Neuronal nicotinic receptors and ligands

280

Neuronal nitric oxide synthase (NNOS) catalyzes one-electron reduction of 2,4,6-trinitrotoluene, resulting in decreased nitric oxide production and increased nNOS gene expression: implication for oxidative stress

281

Neuronal nitric oxide synthase activity is increased during granulomatous inflammation in the colon and caecum of pigs infected with Schistosoma japonicum

282

Neuronal Nitric Oxide Synthase Expression in the Anterior Vaginal Wall of Patients with Stress Urinary Incontinence

283

Neuronal nitric oxide synthase gene transfer decreases [Ca2+]i in cardiac sympathetic neurons

284

Neuronal Nitric Oxide Synthase is Refractory to Mechanism-Based Inactivation in GH3Pituitary Cells

285

Neuronal Nitric Oxide Synthase–Membrane Phospholipid Interactions

286

Neuronal NO synthase (NOS1) is a major candidate gene for asthma

287

Neuronal nuclear antigen (NeuN): a marker of neuronal maturation in the early human fetal nervous system

288

Neuronal organization and cell interactions of the cat stellate ganglion

289

Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging

290

Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity

291

Neuronal Phenomena Associated with Vigilance and Consciousness: From Cellular Mechanisms to Electroencephalographic Patterns,

292

Neuronal plasticity and survival in mood disorders

293

Neuronal polo-like kinase in Alzheimer disease indicates cell cycle changes

294

Neuronal porosome – The secretory portal at the nerve terminal: Its structure–function, composition, and reconstitution

295

Neuronal projections from ventral tegmental area to forebrain structures in rat studied by manganese-enhanced magnetic resonance imaging

296

Neuronal representations of cognitive state: reward or attention?

297

Neuronal stem cells: a tale of promise and caution

298

Neuronal Store-Operated Calcium Entry Pathway as a Novel Therapeutic Target for Huntingtonʹs Disease Treatment Original Research Article

299

Neuronal subpopulations and genetic background in tauopathies: a catch 22 story?

300

Neuronal subserving of behavior before and after chronic ethanol treatment

301

Neuronal substrates of sensory gating within the human brain

302

Neuronal substrates participating in attentional set-shifting of rules for visually guided motor selection: a functional magnetic resonance imaging investigation

303

Neuronal Subtype Specification within a Lineage by Opposing Temporal Feed-Forward Loops

304

Neuronal susceptibility to damage: comparison of the retinas of young, old and old/caloric restricted rats before and after transient ischemia

305

Neuronal synchrony detection on single-electron neural networks

306

Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Downʹs syndrome: a gene expression study

307

Neuronal toxicity of biopolymer-template synthesized ZnO nanoparticles

308

Neuronal, mesenchymal and hematopoietic cell derived from CD34− lin− cell from adult bone marrow

309

Neuronally-expressed necdin gene: an imprinted candidate gene in Prader-Willi syndrome

310

Neuronavigated repetitive transcranial magnetic stimulation in patients with tinnitus: a short case series

311

Neuronavigation assisted endoscopic sinus surgery

312

Neuronavigation for Intraoperative Localization of Cerebral Aneurysms

313

Neuronavigation for transcranial magnetic stimulation (TMS): Where we are and where we are going

314

Neuron-based VLSI architecture for real-time camera distortion correction

315

Neuron-controlled robots

316

Neuron-MOS Parallel Search Hardware for Real-Time Signal Processing

317

Neuronorm is a potent and water soluble neurokinin A receptor antagonist

318

Neurons and neuronal systems involved in the pathophysiologies of Rett syndrome

319

Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimerʹs disease

320

Neurons don’t represent

321

Neurons in amygdala mediate ear pinna vasoconstriction elicited by unconditioned salient stimuli in conscious rabbits

322

Neurons lose inhibitions in epilepsy

323

Neurons regenerate in absence of reactive astrocytes

324

Neurons, Cooperativity and the Role of Noise in Brain

325

Neurons, glia, and plasticity in normal brain aging

326

Neurons, viscose fluids, freshwater polyp hydra-and self-organizing information systems

327

Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke

328

Neuron-specific enolase antibodies in patients with sudden acquired retinal degeneration syndrome

329

Neuron-specific enolase antibodies in patients with sudden acquired retinal degeneration syndrome

330

Neuron-Specific enolase as a marker for acute ischemic stroke: A systematic review

331

Neuron-specific enolase as a marker of the severity and outcome of hypoxic ischemic encephalopathy

332

Neuron-specific enolase in cerebrospinal fluid as a neurochemical marker for brain damage in acute lymphoblastic leukemia

333

Neuron-specific enolase increases in plasma during and immediately after extracorporeal circulation

334

Neuron-specific enolase levels in the cerebrospinal fluid of neurologically healthy children

335

Neuron-specific enolase, nucleotides, nucleosides, purine bases, oxypurines and uric acid concentrations in cerebrospinal fluid of children with meningitis

336

Neuron-specific susceptibility to apolipoprotein E4

337

Neuron-synapse IC chip-set for large-scale chaotic neural networks

338

Neuron-tumor Interaction in Prostate Cancer: Implications and Future Perspective

339

Neuron-type polypyrrole device prepared by electrochemical polymerization method and its properties

340

Neuro-oncology for non-oncologists

341

Neuro-oncology for Nurses; Edited by Douglas Guerrero, Whur Publishers Ltd, £24.50

342

Neuro-oncology: diagnosis in the spotlight

343

Neuro-oncology: new insights and advances in treatment

344

Neuro-oncology: oligodendroglioma and molecular markers

345

Neuro-oncology: setting new standards of management

346

Neuro-oncology: the growing role of chemotherapy in glioma

347

Neuro-Ophthalmologic and Electroretinographic Finding in Pantothenate Kinae-Aociated Neurodegeneration (formerly Hallervorden-patz yndrome)

348

Neuro-Ophthalmologic Preentation of Hemicrania Continua

349

Neuro-ophthalmologic Recovery Following Endoscopic Endonasal Resection of Pituitary Macro-adenomas with Apoplexy

350

Neuro-ophthalmology review manual, revied 5th edition: Lanning B. Kline and Frank J. Bajanda. lack Incorporated: Thorofare, NJ; 2004.288 page$44.95 UDIBN 1-55642-672-0Media type: Review Manual

351

Neuro-Ophthalmology, The Requiite in Ophthalmology. Edited by Timothy J. Martin and Jame J. Corbett. t. Loui, Miouri, Moby Inc., 2000. Index, illutrated, 256 page. $89.00.

352

Neuro-ophthalmology: Neuronal Control of Eye Movements .A. Straube and U. Büttner Editors Basel Karger (2007).

353

Neuro-ophthalmology—Diagnoi and Management. Liu GT, Volpe NJ, Baletta L. New York, W.B. aunder, 2001. 756 page, index, illutrated. About $135.00

354

Neuro-optimal operation of a variable air volume HVAC&R system

355

Neuro-Optometry, Neuro-Optometrist, and Neuro-Optometric Rehabilitative Implications

356

Neuro-otologic Manifestations of Multiple Sclerosis

357

Neuro-otological features of Benign Paroxysmal Vertigo and Benign Paroxysmal Positioning Vertigo in children: A follow-up study

358

Neuropathic agents and pain. New strategies

359

Neuropathic arthropathy of the shoulder associated with syringomyelia: a report of six cases

360

Neuropathic arthropathy of the shoulder associated with syringomyelia: a report of six cases

361

Neuropathic diabetic patients do not have reduced variability of plantar loading during gait

362

Neuropathic elbow arthropathy: A review of six cases

363

Neuropathic gait shows only trends towards increased variability of sagittal plane kinematics during treadmill locomotion

364

Neuropathic injury to the levator ani occurs in 1 in 4 primiparous women

365

Neuropathic manifestations in rheumatoid arthritis : A clinical and electrophysiological assessment in a small sample of Iraqi patients.

366

Neuropathic Orofacial Pain: Proposed Mechanisms, Diagnosis, and Treatment Considerations

367

Neuropathic Osteoarthropathy in a Patient with Congenital Insensitivity to Pain

368

Neuropathic pain

369

NEUROPATHIC PAIN

370

Neuropathic pain

371

Neuropathic pain in hereditary coproporphyria

372

Neuropathic pain in soft tissue complaints

373

Neuropathic pain research pinpoints new role for microglia

374

Neuropathic Pain Treatment Gives Avigen New Lease on Life and Neuromed Follows the Snail Trail

375

Neuropathic Pain Treatment Gives Avigen New Lease on Life and Neuromed Follows the Snail Trail

376

Neuropathic Pain: A Review of Interneuronal Disinhibition

377

Neuropathic pain: aetiology, symptoms, mechanisms, and management

378

Neuropathic symptoms and findings in women with Fabry disease

379

Neuropathie radio-induite du nerf optique après traitement pour cancer du nasopharynx. ہ propos de deux cas et revue de la littérature

380

Neuropathie radio-induite du nerf optique après traitement pour cancer du nasopharynx. ہ propos de deux cas et revue de la littérature

381

Neuropathies of the foot

382

Neuropathogenicity of Equine Herpesvirus 9 in Cattle

383

Neuropathologic study of long term cyanide administration to goats

384

Neuropathological alteration of aquaporin 1 immunoreactive enteric neurons in the streptozotocin-induced diabetic rats

385

Neuropathological analysis of the brainstem and cerebral cortex lesions on epileptogenesis in hereditary dentatorubral-pallidoluysian atrophy

386

Neuropathological assessment of artemether-treated severe malaria

387

Neuropathological Changes in Brain Cortex and Hippocampus in a Rat Model of Alzheimer’s Disease

388

NEUROPATHOLOGICAL CHANGES IN THE PDAPP TRANSGENIC MOUSE MODEL OF ALZHEIMER S DISEASE

389

Neuropathological characteristics and alteration of the dopamine D2 receptor in hypoxic-ischemic basal ganglia necrosis

390

Neuropathological Criteria for the Diagnosis of Alzheimer’s Disease

391

Neuropathological Criteria for the Diagnosis of Alzheimer’s Disease: Are We Really Ready Yet?

392

Neuropathological Diagnosis of Alzheimer’s Disease: A Perspective from Longitudinal Clinicopathological Studies

393

Neuropathological epidemiology of cerebral aging: a study of two genetic polymorphisms

394

Neuropathological findings in the cerebro-oculo-facio-skeletal (Pena-Shokeir II) syndrome

395

Neuropathological markers of impaired cognition in the entorhinal cortex

396

Neuropathological Staging of Alzheimer-Related Lesions: The Challenge of Establishing Relations to Age

397

Neuropathological studies of brain tissue in schizophrenia

398

Neuropathologies of the self: Clinical and anatomical features

399

Neuropathology and Genetics of Dementia, Edited by Tolnay M. and Probst A., Kluwer Academic/Plenum Publ., London, 2000.

400

Neuropathology in controls and demented subjects from the Baltimore longitudinal study of aging

401

Neuropathology of bipolar disorder

402

Neuropathology of chronic chagasic cardiopathy: A diagnostic reassessment

403

Neuropathology of developmental abnormalities

404

Neuropathology of early-infantile epileptic encephalopathy with suppression-bursts; comparison with those of early myoclonic encephalopathy and West syndrome

405

Neuropathology of mitral valve prolapse in man and cardiopulmonary bypass (CPB) surgery in adolescent Yorkshire pigs

406

Neuropathology of prion diseases

407

Neuropathology of the limbic system and brainstem in West syndrome

408

Neuropathology of tuberous sclerosis

409

Neuropathology of variant Creutzfeldt-Jakob disease

410

Neuropathy complicating diffuse infiltrative lymphocytosis

411

Neuropathy in type 1 diabetic renal transplanted patients

412

Neuropathy of the suprascapular nerve and massive rotator cuff tears: a prospective electromyographic study

413

Neuropathy, axonal Na+/K+ pump function and activity-dependent excitability changes in end-stage kidney disease

414

Neuropathy-induced osteopenia in rats is not due to a reduction in weight born on the affected limb

415

Neuro-PD Controller of Structural System to Mitigate Earthquake Vibrations

416

Neuropeptide deficits in schizophrenia vs. Alzheimerʹs disease cerebral cortex

417

Neuropeptide deficits in schizophrenia vs. Alzheimerʹs disease cerebral cortex

418

Neuropeptide Delivery to Synapses by Long-Range Vesicle Circulation and Sporadic Capture

419

Neuropeptide enzyme hydrolysis in human saliva

420

Neuropeptide expression following ligation of the ferret lingual nerve

421

Neuropeptide expression in the ferret trigeminal ganglion following ligation of the inferior alveolar nerve

422

Neuropeptide FF attenuates RANKL-induced differentiation of RAW264.7 cells into osteoclast-like cells

423

Neuropeptide may shift rheumatoid arthritis into remission

424

Neuropeptide specificity of prostaglandin E2-induced activation of splenic and renal sympathetic nerves in the rat

425

Neuropeptide transmitters released from VAN into the NTS play an important role in regulating food intake

426

Neuropeptide Y (NPY) and NPY Y1 receptor in periodontal health and disease

427

Neuropeptide Y (NPY) revealed biological activity in leucocytes of Salmo salar

428

Neuropeptide Y (NPY): Genetic Variation in the Human Promoter Alters Glucocorticoid Signaling, Yielding Increased NPY Secretion and Stress Responses

429

Neuropeptide Y administered into cerebral ventricles stimulates sucrose ingestion in the near-term ovine fetus

430

Neuropeptide Y administration into the amygdala does not affect ethanol consumption

431

Neuropeptide Y and nitrite levels in preeclamptic and normotensive gravid women

432

Neuropeptide Y expression, localization and cellular transducing effects in HUVEC

433

Neuropeptide Y Gene Promoter -399T/C Polymorphism Increases Risk of Ischemic Stroke

434

Neuropeptide Y immunohistochemistry and ultrastructure of developing chromaffin tissue in the cloudy dogfish, Scyliorhinus torazame (Chondrichthyes, Elasmobranchii)

435

Neuropeptide Y in male and female brains of flinders sensitive line, a rat model of depression. Effects of electroconvulsive stimuli

436

Neuropeptide Y in neural crest-derived tumors: Effect on growth and vascularization

437

Neuropeptide Y in the rostral ventrolateral medulla blocks somatosympathetic reflexes in anesthetized rats

438

Neuropeptide Y Inhibits in Vivo Specific Antibody Production in Rats

439

Neuropeptide Y modulation of sympathetic activity in myocardial infarction

440

Neuropeptide Y mRNA expression in interneurons in rat spinal cord

441

Neuropeptide Y rapidly enhances [Ca2+]i transients and Ca2+ sparks in adult rat ventricular myocytes through Y1 receptor and PLC activation

442

Neuropeptide Y receptors; antisecretory control of intestinal epithelial function

443

Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway

444

Neuropeptide Y restores appetite and alters concentrations of GH after central administration to endotoxic sheep

445

Neuropeptide Y signal peptide Pro7 substitution protects against coronary artery atherosclerosis: The Helsinki Sudden Death Study

446

Neuropeptide Y suppresses ethanol drinking in ethanol-abstinent, but not non–ethanol-abstinent, Wistar rats

447

Neuropeptide Y Y1 receptor functional responsiveness is enhanced during cardiomyocyte hypertrophy

448

Neuropeptide Y, α-melanocyte–stimulating hormone, and monoamines in food intake regulation

449

Neuropeptide Y1 Receptor NPY1R: Discovery of Naturally Occurring Human Genetic Variants Governing Gene Expression In Cella as Well as Pleiotropic Effects on Autonomic Activity and Blood Pressure In Vivo

450

Neuropeptide Y1 receptor NPY1R: discovery of naturally occurring human genetic variants governing gene expression in cella as well as pleiotropic effects on autonomic activity and blood pressure in vivo.

451

Neuropeptide Y-Y1 receptor modulates nitric oxide level during stroke in the rat

452

NEUROPEPTIDES (SP an‎d CGRP) AUGMENT IL-1 BETA PRODUCTION IN HSV-INFECTED MACROPHAGES

453

Neuropeptides and endothelial injury in cutaneous vasculitis

454

Neuropeptides and obesity

455

Neuropeptides: opportunities for drug discovery

456

Neuropeptide-Y, cortisol, and subjective distress in humans exposed to acute stress: replication and extension of previous report

457

Neuropharmacological activity of the aqueous leaf extract of Croton zambesicus (euphorbiaceae) in some laboratory animals

458

Neuropharmacological approach against MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine)-induced mouse model of Parkinson’s disease

459

Neuropharmacological Effect of the Rhizome of Drynaria quercifolia in Mice

460

Neuropharmacological Effects of Chassalia curviflora (Rubiaceae) Leaves in Swiss Albino Mice Model

461

Neuro-pharmacological effects of Crinum zeylanicum in mice

462

Neuropharmacological effects of methanolic extracts of Rubus fruticosus L.

463

Neuropharmacological effects of Nigella sativa

464

Neuropharmacological effects of Ocimum basilicum and its constituents

465

Neuropharmacological effects of standardized aqueous stem bark extract of Parkia biglobossa in Wistar rats

466

Neuropharmacological key to cortical plasticity found

467

Neuropharmacological properties of farnesol in Murine model

468

Neuropharmacological studies of ethanolic extract of Vaccinium corymbosum on Alzheimer’s type dementia and catatonia in Swiss albino mice

469

Neuropharmacological studies with spect in neuropsychiatric disorders

470

Neuropharmacology of depression in aging and age-related diseases

471

Neuropharmacology of endogenous, synthetic andphytocannabinoids for pain management

472

Neuropharmacology of timing and time perception

473

Neuropharmacology of timing and time perception: [Cognitive Brain Research 3 (1996) 227–242]

474

Neurophenomenology and the study of self-consciousness

475

Neurophil reactive chlorinating species target tissue plasmalogens: Production of 2-chlorohexadecal

476

Neurophysical theory of coherence and correlations of electroencephalographic and electrocorticographic signals

477

Neurophysiologic and intellectual evaluation of beta-thalassemia patients

478

Neurophysiologic assessment of mucopolysaccharidosis III

479

Neurophysiologic consequences of neonatal ethanol exposure in the rat

480

Neurophysiologic correlates of deficient phonological representations and object naming in prematurely born children

481

Neurophysiologic correlates of psychiatric disorders and potential applications in epilepsy

482

Neurophysiologic detector—a selective and sensitive tool in high-performance liquid chromatography

483

Neurophysiologic findings in early acute inflammatory demyelinating polyradiculoneuropathy

484

Neurophysiological and behavioral concomitants of mild brain injury in collegiate athletes

485

Neurophysiological and behavioral indices of time pressure effects on visuomotor task performance

486

Neurophysiological and behavioural evidence for an olfactory function for the dorsal organ and a gustatory one for the terminal organ in Drosophila melanogaster larvae

487

Neurophysiological and functional MRI evidence of reorganization of cortical motor areas in cerebral arteriovenous malformation

488

Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes

489

Neurophysiological assessment of the sedative and analgesic effects of a constant rate infusion of dexmedetomidine in the dog

490

Neurophysiological assessment of trigeminal nerve reflexes in disorders of central and peripheral nervous system

491

Neurophysiological bases underlying the organization of intentional actions and the understanding of others’ intention

492

Neurophysiological changes associated with psychiatric symptoms in HIV-infected individuals without AIDS

493

Neurophysiological Changes Associated with Selective Neuronal Damage in Hippocampus following Transient Forebrain Ischemia

494

Neurophysiological characteristics of photophobia in migraine

495

Neurophysiological correlate of clinical signs in Parkinsonʹs disease

496

Neurophysiological Correlates of Affiliative Behaviour between Humans and Dogs

497

Neurophysiological correlates of subjective significance

498

Neurophysiological correlates of the recognition of facial expressions of emotion as revealed by magnetoencephalography

499

Neurophysiological effects of recurrent laryngeal and thoracic vagus nerves on mediating the neurogenic inflammation of the trachea, bronchi, and esophagus of rats

500

Neurophysiological evaluation of symptomatically unaffected muscles in post polio syndrome (PPS)

501

Neurophysiological evaluation of vigilance in epileptic patients on monotherapy with lamotrigine

502

Neurophysiological evidence for categorical perception of color

503

Neurophysiological evidence of cognitive inhibition anomalies in persons with major depressive disorder

504

Neurophysiological follow-up of motor cortical output in stroke patients

505

Neurophysiological index is a marker of functional impairment in amyotrophic lateral sclerosis

506

Neurophysiological indices of attention to speech in children with specific language impairment

507

Neurophysiological indices of strategy development and skill acquisition

508

Neurophysiological investigation of a chronic sensory ataxia

509

Neurophysiological marker of inhibition distinguishes language groups on a non-linguistic executive function test

510

Neurophysiological markers in familial amyloid polyneuropathy patients: Early changes

511

Neurophysiological markers of contextual processing: The relationship between P3b and Gamma synchrony and their modulation by arousal, performance and individual differences

512

Neurophysiological markers of early language acquisition: from syllables to sentences

513

Neurophysiological mechanisms underlying motor evoked potentials in anesthetized humans.: Part 1. Recovery time of corticospinal tract direct waves elicited by pairs of transcranial electrical stimuli

514

Neurophysiological mechanisms underlying motor evoked potentials in anesthetized humans.: Part 2. Relationship between epidurally and muscle recorded MEPs in man

515

Neurophysiological Methods in Occupational and Environmental Health: Methodology and Recent Findings

516

Neurophysiological monitoring in vascular surgery

517

Neurophysiological Responses to Traumatic Reminders in the Acute Aftermath of Serious Motor Vehicle Collisions Using [15O]-H2O Positron Emission Tomography

518

Neurophysiological self-control: Modulation in all things

519

Neurophysiological signals of working memory in normal aging

520

Neurophysiological signs of cocaine dependence: Increased electroencephalogram beta during withdrawal

521

Neurophysiological study in Pelizaeus-Merzbacher disease

522

Neurophysiological study of corticomotor pathways in restless legs syndrome

523

Neurophysiological study of facial chorea in patients with Huntingtonʹs disease

524

Neurophysiological study of secondary synchronous occipito-frontopolar spikes in childhood

525

Neurophysiological study on possible protective and therapeutic effects of Sidr (Zizyphus spina-christi L.) leaf extract in male albino rats treated with pentylenetetrazol

526

Neurophysiological study on sensorimotor control mechanism in superior colliculus of echolocating bat

527

Neurophysiological techniques in patients who are secondarily non-responsive to Botulinum toxin

528

Neurophysiologist reprimanded by UK General Medical Council

529

Neurophysiology and neuroanatomy of reflexive and volitional saccades as revealed by lesion studies with neurological patients and transcranial magnetic stimulation (TMS)

530

Neurophysiology and neuroanatomy of reflexive and volitional saccades: Evidence from studies of humans

531

Neurophysiology and neuroanatomy of reflexive and voluntary saccades in non-human primates

532

Neurophysiology and neuroanatomy of smooth pursuit in humans

533

Neurophysiology and neuroanatomy of smooth pursuit: Lesion studies

534

Neurophysiology for Detection of High Risk for Psychosis

535

Neurophysiology in the intensive care unit: Size (of surals) matters

536

Neurophysiology of Parkinsonʹs disease: from basic research to clinical correlates

537

Neurophysiology of Rett syndrome

538

Neurophysiology of Social Conduct and Impact of Adverse Exposures

539

Neurophysiology of spasms

540

Neurophysiology of swallowing

541

Neurophysiology of the neurogenic lower urinary tract disorders

542

Neurophysiology of Touretteʹs syndrome: pathophysiological considerations

543

Neurophysiology of unimanual motor control and mirror movements

544

Neurophysiology reference tome

545

Neuro-PID tracking control of a discharge air temperature system

546

Neuropil Alteration of the Habenula Nucleus in the Experimental Model of Schizophrenia Induced by Ketamine

547

Neuropilin-1 Expreion by Endothelial Cell and Retinal Pigment Epithelial Cell in Choroidal Neovacular Membrane

548

Neuropilins and semaphorins — from angiogenesis to autoimmunity

549

Neuroplasticity and schizophrenia

550

Neuroplasticity as a function of second language learning: Anatomical changes in the human brain

551

Neuroplasticity changes during space flight Original Research Article

552

Neuroplasticity Changes of Rat Brain by Musical Stimuli during Fetal Period

553

Neuroplasticity of face primary motor cortex control of orofacial movements

554

Neuroplasticity of face sensorimotor cortex and implications for control of orofacial movements

555

Neuroplasticity: Evidence from aphasia

556

Neuropolitics gone mad

557

Neuroprophylaxis with aminophylline and magnesium sulfate?

558

Neuroprostheses for leg function after spinal-cord injury

559

Neuroprotection after cardiac arrest

560

Neuroprotection After Traumatic Brain Injury: Is There any Hope?

561

Neuroprotection against ischemic brain injury conferred by a novel nitrate ester

562

Neuroprotection and anxiety like behavior reduction of Allium hirtifolium and Astragalus hamosus in the AB-injected rat

563

NEURO-PROTECTION AND NEURO-THERAPY EFFECTS OF Acalypha indica Linn. WATER EXTRACT EX VIVO ON Musculus gastrocnemius Frog

564

Neuroprotection and pharmacotherapy for motor symptoms in Parkinsonʹs disease

565

Neuroprotection and the role of neuroglobin

566

Neuroprotection by KATP channels

567

Neuroprotection by the Metabolic Antioxidant α-Lipoic Acid

568

Neuroprotection disappointment yet aGAIN

569

Neuroprotection Effect of Quercetin on TNF- Levels and Gene Expression of Caspase 3 in MPTP-Induced Male NMRI Mice

570

Neuroprotection failure in stroke

571

Neuroprotection for acute ischaemic stroke: hope reignited

572

Neuroprotection for Parkinsonʹs disease: a call for clinically riven experimental design

573

Neuroprotection in acute ischaemic stroke: a tale of for whom the bell tolls?

574

Neuroprotection in Cardiac Surgery

575

Neuroprotection in epilepsy: The Holy Grail of antiepileptogenic therapy

576

Neuroprotection in Glaucoma

577

Neuroprotection in Glaucoma

578

Neuroprotection in multiple sclerosis

579

Neuroprotection in Parkinsonʹs Disease

580

Neuroprotection in Parkinsonʹs disease: and now for something completely different?

581

Neuroprotection of a sesamin derivative, 1, 2-bis [(3-methoxy- phenyl) methyl] ethane-1, 2-dicaroxylic acid (MMEDA) against ischemic and hypoxic neuronal injury

582

Neuroprotective (+) 3S, 4S cannabinoids with modified 5′-side chain

583

Neuroprotective activities of acai berries (Euterpe sp.): A review

584

Neuroprotective activity of omega-3 fatty acids against epilepsy-induced hippocampal damage: Quantification with immunohistochemical for calcium–binding proteins

585

Neuroprotective adaptations in hibernation: therapeutic implications for ischemia-reperfusion, traumatic brain injury and neurodegenerative diseases

586

Neuroprotective Agents for Management of Parkinson’s disease

587

Neuroprotective agents: Cannabinoids

588

Neuroprotective and Antiamnesic Effects of Mitragyna inermis Willd (Rubiaceae) on Scopolamine-Induced Memory Impairment in Mice

589

Neuroprotective and anti-inflammatory effects of flavonoids isolated from Rhus verniciflua in neuronal HT22 and microglial BV2 cell lines

590

Neuroprotective and Anti-inflammatory Role of Atorvastatin and Its Interaction with Nitric Oxide (NO) in Chronic Constriction Injury-induced Neuropathic Pain

591

Neuroprotective and anti-neuroinflammatory activity of frankincense in bile duct ligation-induced hepatic encephalopathy

592

Neuroprotective and memory enhancing effects of Zataria multiflora in lipopolysaccharide-treated rats

593

Neuroprotective and neurorestorative signal transduction mechanisms in brain aging: modification by genes, diet and behavior

594

Neuroprotective and Nootropic Activity of Carica Papaya Seeds on Diabetes induced Cognitive Decline in Rats

595

Neuroprotective and Nootropic Drug Noopept Rescues α-Synuclein Amyloid Cytotoxicity

596

Neuroprotective antioxidant effect of sex steroid hormones in traumatic brain injury

597

Neuroprotective biflavonoids of Chamaecyparis obtusa leaves against glutamate-induced oxidative stress in HT22 hippocampal cells

598

Neuroprotective Consequences of Postconditioning on Embolic Model of Cerebral Ischemia in Rat

599

Neuroprotective Effect of Matricaria chamomilla Extract on Motor Dysfunction Induced by Transient Global Cerebral Ischemia and Reperfusion in Rat

600

Neuroprotective Effect of 4T1 and Sertoli Cells CoTransplantation in Animal Model of Brain Ischemia

601

Neuroprotective effect of Acorus calamus Linn. extract on a rat model of chronic constriction injury of median nerve-induced peripheral neuropathy

602

Neuroprotective effect of ACTH (4-9) in degeneration of hippocampal nerve cells caused by dexamethasone: morphological, immunocytochemical and ultrastructural studies

603

Neuroprotective effect of agmatine in rats with transient cerebral ischemia using MR imaging and histopathologic evaluation

604

Neuroprotective effect of alkyl hydroxytyrosyl ethers in rat brain slices subjected to a hypoxia-reoxygenation model

605

Neuroprotective effect of berberine chloride on cognitive impairment and hippocampal damage in experimental model of vascular dementia

606

Neuroprotective effect of blackberry (Rubus sp.) polyphenols is potentiated after simulated gastrointestinal digestion

607

Neuroprotective Effect of Celastrus Paniculatus Seed Extract on Epilepsy and Epilepsy-associated Cognitive Deficits

608

Neuroprotective Effect of Coenzyme Q10 in Chronic Constriction Injury-Induced Neuropathic Pain in Rat

609

Neuroprotective effect of Coenzyme Q10 in hippocampal injury in Balb/c mouse

610

Neuroprotective effect of Coenzyme Q10 on ischemic hemisphere in aged mice with mutations in the amyloid precursor protein

611

Neuroprotective Effect of DAHP via Antiapoptosis in Cerebral Ischemia

612

Neuroprotective effect of Decalepis hamiltonii roots against ethanol-induced oxidative stress

613

Neuroprotective effect of dimethyl fumarate in stroke: The role of nuclear factor erythroid 2-related factor 2

614

Neuroprotective Effect of Erythropoietin in Postoperation Cervical Spinal Cord Injury: Case Report and Review

615

Neuroprotective effect of ethanolic leaf extract of Commiphora caudata (Wight Arn) against lipopolysaccharide-induced neurotoxicity in Wistar rats

616

Neuroprotective Effect of Exogenous Melatonin on Dopaminergic Neurons of the Substantia Nigra in Ovariectomized Rats

617

Neuroprotective effect of geraniol and curcumin in an acrylamide model of neurotoxicity in Drosophila melanogaster: Relevance to neuropathy

618

Neuroprotective effect of ginger on anti-oxidant enzymes in streptozotocin-induced diabetic rats

619

Neuroprotective effect of hexasulfobutylated C60 on rats subjected to focal cerebral ischemia

620

Neuroprotective effect of Launaea taraxacifolia against neuroinflammation, memory loss and neurobehavioral deficit in a rat model of hypertension: biochemical and immunohistochemical approaches

621

Neuroprotective effect of L-deprenyl on the expression level of the Mst1 gene and inhibition of apoptosis in rat-model spinal cord injury

622

Neuroprotective effect of melatonin in a rat model ofstreptozotocin-induced diabetic neuropathy: Light andelectron microscopic study

623

Neuroprotective Effect of Melatonin in the Hippocampus of Rat’s Brain in Normal Aging Model

624

Neuroprotective Effect of Melatonin on Brain Damage Induced by Acute Global Cerebral Ischemia in Cats

625

Neuroprotective effect of memantine on serum S100-B levels after on-pump coronary artery bypass graft surgery: A randomized clinical trial

626

Neuroprotective effect of methanolic extract of Sargassum wightii on rotenone-induced parkinsonism-like symptoms in Wistar albino rats

627

Neuroprotective Effect of Paroxetine on Memory Deficit Induced by Cerebral Ischemia after Transient Bilateral Occlusion of Common Carotid Arteries in Rat

628

Neuroprotective effect of p-coumaric acid in rat model of embolic cerebral ischemia

629

Neuroprotective Effect of Pentoxifylline on 3,4-Methylenedioxymethamphetamine-Induced Apoptosis in CA1 Cells of Wistar Rat Hippocampus

630

Neuroprotective Effect of Quercetin Encapsulated Liposomes: A Novel Therapeutic Strategy against Alzheimerʹs Disease

631

Neuroprotective Effect of Quercetin in a Model of Parkinson’s Disease in Rat: A histochemical Analysis

632

Neuroprotective effect of selective antegrade cerebral perfusion during prolonged deep hypothermic circulatory arrest: Cerebral metabolism evidence in a pig model

633

Neuroprotective effect of thymoquinone in acrylamide-induced neurotoxicity in Wistar rats

634

Neuroprotective Effect of Thymoquinone, the Nigella Sativa Bioactive Compound, in 6-Hydroxydopamine-Induced Hemi-Parkinsonian Rat Model

635

Neuroprotective Effect of Total and Sequential Extract of Scrophularia striata Boiss. in Rat Cerebellar Granule Neurons Following Glutamate- Induced Neurotoxicity: An In-vitro Study

636

NEUROPROTECTIVE EFFECT OF VITAMIN C AGAINST PTZ INDUCED APOPTOTIC NEURODEGENERATION IN ADULT RAT BRAIN

637

Neuroprotective effect of water lily (Nymphaea pubescens Willd) seed ethanolic extract against trimethyltin-induced cognitive impairment and neurodegeneration in mice

638

Neuroprotective Effect of Zataria Multiflora Essential Oil on Rats With Alzheimer Disease: A Mechanistic Study

639

Neuroprotective Effects of 1,8-Cineole on Apoptosis Inhibition and Bcl-2/Caspase-3 mRNA Expression in the Hippocampus of Epileptic Pilocarpine Model Rats

640

Neuroprotective Effects of Acetyl-l-Carnitine After Stroke in Rats, , ,

641

Neuroprotective effects of alpha-lipoic acid on radiation-induced brainstem injury in rats

642

Neuroprotective effects of atomoxetine against traumatic spinal cord injury in rats

643

Neuroprotective Effects of Berberine Hydrochloride on Methamphetamine-induced Cognitive Dysfunction: Immunohistochemical and Behavioral Studies in Rats

644

Neuroprotective Effects of Bone Marrow Mesenchymal Stem Cells on Bilateral Common Carotid Arteries Occlusion Model of Cerebral Ischemia in Rat

645

Neuroprotective effects of caffeine against beta-amyliod neurotoxicity: The involvement of glycogen synthase kinase-3β protein

646

Neuroprotective Effects of Carnosic Acid in an Experimental Model of Alzheimer’s disease in Rats

647

Neuroprotective effects of carvacrol against Alzheimer’s disease and other neurodegenerative diseases: A review

648

Neuroprotective effects of celastrol on sciatic nerve transection model in male Wistar rats

649

Neuroprotective Effects of Chrysin Mediated by Estrogenic Receptors Following Cerebral Ischemia and Reperfusion in Male Rats

650

Neuroprotective effects of cobalt ferrite nanoparticles coated with sumac on damaged sciatic nerve recovery

651

Neuroprotective effects of cognitive enrichment

652

Neuroprotective Effects of Combined Treatment with Minocycline and Olfactory Ensheathing Cells Transplantation against Inflammation and Oxidative Stress after Spinal Cord Injury

653

Neuroprotective effects of Coriandrum sativum and its constituent, linalool: A review

654

Neuroprotective effects of crocin on the histopathological alterations following brain ischemia-reperfusion injury in rat

655

Neuroprotective effects of curculigoside against NMDA-induced neuronal excitoxicity in vitro

656

Neuroprotective Effects of Curcumin Against Transient Global Ischemia are Dose and Area Dependent

657

Neuroprotective Effects of Curcumin on the Proliferation and Viability of Neural Stem Cells against H2O2

658

Neuroprotective effects of cystamine in aged parkinsonian mice

659

Neuroprotective Effects of Ellagic Acid in a Rat Model of Parkinsonʹs Disease

660

Neuroprotective Effects of Epigallocatechin-3-Gallate in an Experimental Model of Alzheimer’s Disease in Rat: A Histological Study

661

Neuroprotective effects of Equisetum telmateia in rat

662

Neuroprotective effects of Eriobotrya japonica against β-amyloid-induced oxidative stress and memory impairment

663

Neuroprotective Effects of Erythropoietin in Acute Ischemic Stroke

664

Neuroprotective Effects of Exercise on Brain Edema and Neurological Movement Disorders Following the Cerebral Ischemia and Reperfusion in Rats

665

Neuroprotective Effects of Fe3O4 Nanoparticles Coated with Omega-3 as a Novel Drug for Recovery of Sciatic Nerve Injury in Rats

666

Neuroprotective effects of flavones on hydrogen peroxide-induced apoptosis in SH-SY5Y neuroblostoma cells

667

Neuroprotective effects of gallic acid in a rat model of traumatic brain injury: behavioral, electrophysiological, and molecular studies

668

Neuroprotective Effects of Herbal Extract (Rosa canina, Tanacetum vulgare and Urtica dioica) on Rat Model of Sporadic Alzheimer’s Disease

669

Neuroprotective effects of intense training and thyme honey on hippocampal cognitive pathways in diabetic rats

670

Neuroprotective Effects of Isoquercetin: An In Vitro and In Vivo Study

671

Neuroprotective effects of kobophenol A against the withdrawal of tropic support, nitrosative stress, and mitochondrial damage in SH-SY5Y neuroblastoma cells

672

Neuroprotective Effects of Medicinal Plants and Their Constituents on Different Induced Neurotoxicity Methods: A Review

673

Neuroprotective Effects of Memantine in the Retina of Glaucomatous Rats: An Electron Microscopic Study

674

Neuroprotective effects of naturally occurring biflavonoids

675

Neuroprotective effects of neolignans isolated from Magnoliae Cortex against glutamate-induced apoptotic stimuli in HT22 cells

676

Neuroprotective Effects of Normobaric Hyperoxia and Transplantation of Encapsulated Choroid Plexus Epithelial Cells on The Focal Brain Ischemia

677

Neuroprotective effects of oral gallic acid against oxidative stress induced by 6-hydroxydopamine in rats

678

Neuroprotective effects of Pinus eldarica in a mouse model of pentylenetetrazole-induced seizures

679

Neuroprotective Effects of Pramipexole in Parkinson s Disease Induced by Rotenone in Mice

680

Neuroprotective Effects of Progesterone on Damage Elicited by Acute Global Cerebral Ischemia in Neurons of the Caudate Nucleus

681

Neuroprotective effects of propolis and caffeic acid phenethyl ester (CAPE) on the radiation-injured brain tissue (Neuroprotective effects of propolis and CAPE)

682

Neuroprotective effects of resveratrol on embryonic dorsal root ganglion neurons with neurotoxicity induced by ethanol

683

Neuroprotective effects of rosemary extract on white matter of prefrontal cortex in old rats

684

Neuroprotective effects of Salvia aristata Aucher ex Benth. on hydrogen peroxide induced apoptosis in SH-SY5Y neuroblastoma cells

685

Neuroprotective effects of Schisandrin B against transient focal cerebral ischemia in Sprague–Dawley rats

686

Neuroprotective effects of selenium and ginkgo biloba extract (EGb761) against ischemia and reperfusion injury in rat brain

687

Neuroprotective Effects of Semaglutide in Endotoxemia Mouse Model

688

Neuroprotective effects of silymarin on sodium fluoride-induced oxidative stress

689

Neuroprotective effects of statins may not be related to total and low-density lipoprotein cholesterol lowering

690

Neuroprotective effects of Tacca chantrieri Andre against lipopolysaccharide-induced cognitive impairment and neuroinflammation

691

Neuroprotective effects of Tiliacora triandra leaf extract in a mice model of cerebral ischemia reperfusion

692

Neuroprotective Effects of Transplanted Mesenchymal Stromal Cells-derived Human Umbilical Cord Blood Neural Progenitor Cells in EAE

693

Neuroprotective Effects of Vitamin D on Patients With Traumatic Brain Injury: A Clinical Trial

694

Neuroprotective Effects of Vitexin and Cajanus cajan Extract Against Pb-induced Neurotoxicity in Wistar Rats

695

Neuroprotective effects of voluntary wheel running and eriobotrya japonica flower extract on Parkinsonian rats

696

Neuroprotective effects of walnut (Juglans regia L.) in nervous system disorders: A comprehensive review

697

Neuroprotective effects of Wharton’s jelly-derived mesenchymal stem cells on motor deficits due to Parkinson’s disease

698

Neuroprotective effects of Withania coagulans root extract on CA1 hippocampus following cerebral ischemia in rats

699

Neuroprotective effects of xanthone derivative of Garcinia mangostana against lead-induced acetylcholinesterase dysfunction and cognitive impairment

700

Neuroprotective effects of Z-ajoene, an organosulfur compound derived from oil-macerated garlic, in the gerbil hippocampal CA1 region after transient forebrain ischemia

701

Neuroprotective effects of α-lipoic acid and its positively charged amide analogue

702

Neuroprotective gene profile in the brain of magnesium-deficient mice

703

Neuroprotective mechanism of bromocriptine

704

Neuroprotective or neurotoxic activity of 1-methyl-1,2,3,4-tetrahydroisoquinoline and related compounds

705

Neuroprotective Plants; What, How, an‎d Why? A Narrative Review

706

Neuroprotective potential of some terebinth coffee brands and the unprocessed fruits of Pistacia terebinthus L. and their fatty and essential oil analyses

707

Neuroprotective Potential of Trans-Anethole Following Crush Injury of the Sciatic Nerve in Rats

708

Neuroprotective Properties of Melissa Officinalis L. Extract Against Ecstasy-Induced Neurotoxicity

709

Neuroprotective properties of Melissa officinalisafter hypoxic-ischemic injury both in vitro and in vivo

710

Neuroprotective Properties of Photobiomodulation in Retinal Regeneration in Rats: Perspectives From Interaction Levels

711

Neuroprotective properties of Spanish red wine and its isolated polyphenols on astrocytes

712

Neuroprotective role of curcumin on the hippocampus against the structural and serological alterations of streptozotocin-induced diabetes in Sprague Dawely rats

713

Neuroprotective role of vitamin D3 in colchicine-induced Alzheimer’s disease in rats

714

Neuroprotective roles of flavonoid “hispidulin” in the central nervous system: A review

715

Neuroprotective Strategies in the Perioperative Period: A Systematic Review

716

Neuroprotective therapy for acute ischaemic stroke: down, but not out

717

Neuroprotective Treatment With FK506 Reduces Hippocampal Damage and Prevents Learning and Memory Deficits After Transient Global Ischemia in Rat

718

Neuroprotective, antimicrobial, antioxidant, chemotherapeutic, and antidiabetic properties of Salvia Reuterana: A mini review

719

Neuroproteomics comes of age

720

Neuropsychiaric perspective and recommendations

721

Neuropsychiatric and neuropsychological manifestations of central pontine myelinolysis

722

Neuropsychiatric and Psychosocial Issues of Patients With Hepatitis C Infection: A Selective Literature Review

723

Neuropsychiatric aspects in Munchausenʹs syndrome

724

Neuropsychiatric aspects of epilepsy in children

725

Neuropsychiatric aspects of patients with hypothalamic hamartomas

726

Neuropsychiatric changes after liver transplantation

727

Neuropsychiatric Complications Following Liver Transplantation

728

NEUROPSYCHIATRIC COMPLICATIONS IN LIVER TRANSPLANT PATIENTS IN A TERTIARY HOSPITAL IN SINGAPORE

729

Neuropsychiatric Complications of COVID-19: What is to be Expected

730

Neuropsychiatric effects of medications for allergic diseases

731

Neuropsychiatric features of systemic lupus erythematosus

732

Neuropsychiatric Function and Dehydroepiandrosterone Sulfate in Elderly Women: A Prospective Study

733

Neuropsychiatric Illness: A Case for Impaired Neuroplasticity and Possible Quantum Processing Derailment in Microtubules

734

Neuropsychiatric implications of basal ganglia dysfunction

735

Neuropsychiatric Lupus

736

Neuropsychiatric lupus erythematosus: A 10-year prospective study on the value of diagnostic tests,

737

Neuropsychiatric Manifestations in a Patientwith Panhypopituitarism

738

Neuropsychiatric Manifestations of COVID-19 in Hospitalized Pediatrics: A Multicenter Cross-sectional Study

739

Neuropsychiatric Manifestations of Partial Agenesis ofthe Corpus Callosum: A Case Report and Literature Review

740

Neuropsychiatric perspectives on nodding syndrome in northern Uganda: a case series study and a review of the literature

741

Neuropsychiatric profiles of patients with juvenile myoclonic epilepsy treated with valproate or topiramate

742

Neuropsychiatric reaction induced by abacavir

743

Neuropsychiatric reactions with mefloquine chemoprophylaxis

744

Neuropsychiatric sequelae in a case of St. Louis Encephalitis

745

Neuropsychiatric Symptoms As The First Manifestation of Juvenile Systemic Lupus Erythematosus: A Complicated Case With Klinefelterʹʹs Syndrome

746

Neuropsychiatric Syndromes and Occupational Exposure to Zinc Phosphide in Egypt

747

Neuropsychiatric systemic lupus erythematosus: Correlation of brain MR imaging, CT, and SPECT

748

Neuropsychiatric toxicity of Ifosfamide in patients admitted for chemotherapy

749

Neuropsychiatry and Behavioral Neuroscience

750

Neuropsychiatry in old age : by C. Stefanis and H. Hippius, 1996, Hogrefe & Huber Publishers, Seattle, USA, 171 pages, US$ 32, ISBN 0-88937-137-7

751

Neuropsychiatry, second edition.R.B. Schiffer, S.M. Roa and B.S. Fogel, Editors, Lippincott Williams & Wilkins, Philadelphia (2003) $169, 1312 pages.

752

Neuropsychiatry—a discipline for the future

753

Neuropsychiatryʹs offspring

754

Neuropsychiatry—The mind embrained?

755

Neuro-Psychoanalysis May Enliven the Mindbrain Sciences

756

Neuropsychologic and Functional Recovery From Severe Carbon Monoxide Poisoning Without Hyperbaric Oxygen Therapy, , ,

757

Neuropsychologic Changes After Coronary Artery Bypass Grafting: Use of Reliable Change Indices

758

Neuropsychologic functioning among the nonpsychotic relatives of schizophrenic patients: the effect of genetic loading

759

Neuropsychologic Impairment in Patients with Nonepileptic Seizures

760

Neuropsychologic impairments in bipolar and unipolar mood disorders on the CANTAB neurocognitive battery

761

Neuropsychologic Theory and Findings in Attention-Deficit/Hyperactivity Disorder: The State of the Field and Salient Challenges for the Coming Decade

762

Neuropsychological abnormalities in cirrhosis include learning impairment

763

Neuropsychological and anatomical correlates of E4 in Alzheimerʹs disease

764

Neuropsychological and behavioral disorders as presentation symptoms in two brothers with early-infantile Niemann-Pick type C

765

Neuropsychological and cognitive psychophysiological substrates of impulsive aggression

766

Neuropsychological and Diagnostic Differences Between Recidivistically Violent Not Criminally Responsible and Mentally Ill Prisoners

767

Neuropsychological and emotional changes during simulated microgravity: effects of triiodothyronine, alendronate, and testosterone

768

Neuropsychological and Emotional Functioning in Patients with Cushing's Syndrome

769

Neuropsychological and mood effects of ketamine in electroconvulsive therapy: A randomised controlled trial

770

Neuropsychological and neurological correlates in an elderly rural population

771

Neuropsychological and neurophysiological deficits in extremely high velocity traumatic brain injury: A case report

772

Neuropsychological and Neuropsychiatric Deficits Following Traumatic Brain Injury: Common Patterns and Neuropathological Mechanisms

773

Neuropsychological and psychiatric changes after deep brain stimulation for Parkinsonʹs disease: a randomised, multicentre study

774

Neuropsychological and psychiatric impact of add-on titration of pregabalin versus levetiracetam: A comparative short-term study

775

Neuropsychological and QEEG assessment of adult ADHD

776

Neuropsychological aspects of chronic relapsing pancreatitis: A longitudinal case study

777

Neuropsychological aspects of epilepsy surgery

778

Neuropsychological aspects of Tourette syndrome: A review

779

Neuropsychological aspects of type of epilepsy and etiological factors in adults

780

Neuropsychological assessment and volumetric magnetic resonance imaging of the corpus callosum in dementia

781

Neuropsychological Assessment In Epilepsy Surgery – Preliminary Experience In A Rural Tertiary Care Hospital In North East Malaysia

782

Neuropsychological assessment in patients evaluated for hyperthermia for metastatic nonsmall lung carcinoma (FDA phase 1 and phase 2)

783

Neuropsychological assessment of a rare systemic vascular disorder: a case study of Rendu—Osler—Weber syndrome

784

Neuropsychological Assessment of Organic Solvent Effects in South Africa: Test Selection, Adaptation, Scoring, and Validation Issues

785

Neuropsychological assessment of persons with physical disability, visual impairment or blindness, and hearing impairment or deafness

786

Neuropsychological assessment of relatively intact individuals: Psychometric lessons from an HIV+ sample

787

Neuropsychological assessment of the blind and visually impaired

788

Neuropsychological assessments before and aftertreatment in patients with anorexia nervosa and bulimianervosa

789

Neuropsychological change following gamma knife surgery in patients with left temporal lobe epilepsy: a review of three cases

790

Neuropsychological changes and treatment compliance in older adults with sleep apnea

791

Neuropsychological Changes in Complex Regional Pain Syndrome (CRPS)

792

Neuropsychological characterization of hepatic encephalopathy

793

Neuropsychological complaint base rates in personal injury, revisited

794

Neuropsychological consequences of bilateral deep brain stimulation of the subthalamic nucleus for the treatment of Parkinsonʹs disease: A 1-year longitudinal follow-up

795

Neuropsychological consequences of HIV in children: A review of current literature

796

Neuropsychological consequences of right thalamic haemorrhage: Case study and review

797

Neuropsychological consequences of sequential concussions in a female college basketball player

798

Neuropsychological correlates between working memory and executive functioning

799

Neuropsychological correlates of adjunct therapy with a nutritional/vitamin supplement in a medical patient sample

800

Neuropsychological Correlates of Community Function among Major Depressive Disorder Outpatients without Comorbidity in Hong Kong: An Exploratory Cross‑Sectional Study

801

Neuropsychological correlates of dominance, warmth, and extraversion in neurodegenerative disease

802

Neuropsychological correlates of Gulf War syndrome

803

Neuropsychological correlates of homocysteine levels in euthymic bipolar patients

804

Neuropsychological Correlates of Methylphenidate Treatment in Adult ADHD With and Without Depression

805

Neuropsychological correlates of opioid dependence and withdrawal

806

Neuropsychological correlates of psychopathic traits in a non-incarcerated sample

807

Neuropsychological correlates of psychotic features in major depressive disorders: a review and meta-analysis

808

Neuropsychological correlates of self-reported impulsive aggression in a college sample

809

Neuropsychological correlates of violence and aggression: A review of the clinical literature

810

Neuropsychological decline following herpes zoster without encephalitis: A case study

811

Neuropsychological Decomposing Stroop Interference Into Different Cognitive Monitoring: An Exploratory Factor Analysis

812

Neuropsychological deficit profiles in senile dementia of the Alzheimerʹs type

813

Neuropsychological deficits among patients with late-onset minor and major depression

814

Neuropsychological deficits associated with chronic hepatitis C among male veterans

815

Neuropsychological deficits in bipolar depression persist after successful antidepressant treatment

816

Neuropsychological deficits in marijuana smokers

817

Neuropsychological deficits in probands from multiply-affected schizophrenic families

818

Neuropsychological deficits of patients with chronic or acute cerebellar lesions

819

Neuropsychological developmental change in a case with Noonan syndrome: longitudinal assessment

820

Neuropsychological Disorders in Patients with Brain Tumor

821

Neuropsychological dissociations between motion and form perception suggest functional organization in extrastriate cortical regions in the human brain

822

Neuropsychological double dissociation between linguistic levels: Clinical linguistic evidence from Iranian aphasic patients

823

Neuropsychological dysfunction after minimally invasive direct coronary artery bypass grafting

824

Neuropsychological Dysfunction in Children with Borderline Personality Disorder Features: A Preliminary Investigation

825

Neuropsychological dysfunction in patients suffering from end-stage chronic obstructive pulmonary disease

826

Neuropsychological dysfunction in patients with end-stage pulmonary disease: lung transplant evaluation

827

Neuropsychological dysfunction in patients with end-stage pulmonary disease: Lung transplant evaluation

828

Neuropsychological dysfunction in schizotypal personality disorder: A profile analysis

829

Neuropsychological Effects of Chronic Exposure to Environmental Dioxins and Furans

830

Neuropsychological effects of epilepsy and antiepileptic drugs

831

Neuropsychological effects of exposure to sheep dip

832

Neuropsychological effects of long-term exposure to organophosphates in sheep dip

833

Neuropsychological effects of seizures

834

Neuropsychological effects of stress on social phobia with and without comorbid depression

835

Neuropsychological evaluation in rehabilitation planning and evaluation of functional skills

836

Neuropsychological evaluation in the diagnosis and management of sports-related concussion

837

Neuropsychological Evaluation of Older Children : By Ralph M. Reitan and Deborah Wolfson, South Tucson, AZ: Neuropsychology Press, 1992. + 814 pp

838

Neuropsychological evidence for dimensional schizotypy: Implications for creativity and psychopathology

839

Neuropsychological exploration of alleged mold neurotoxicity

840

Neuropsychological explorations of memory and cognition: Essay in honor of Nelson butters :Eidted by Laird S. Cermak, N ew York: Plenum Press, 1994.

841

Neuropsychological features of diffuse Lewy body disease

842

Neuropsychological Features of Multiple Sclerosis: Impact and Rehabilitation

843

Neuropsychological findings in adult attention deficit disorder

844

Neuropsychological findings in young-adult stroke patients

845

Neuropsychological follow-up of high risk infants at school age: Wechsler Verbal-Performance discrepancies

846

Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimers disease

847

Neuropsychological function and psychosocial status of alcohol rehabilitation program residents

848

Neuropsychological function in adults with attention-deficit hyperactivity disorder

849

Neuropsychological function in female victims of intimate partner violence with and without posttraumatic stress disorder

850

Neuropsychological function in unmedicated recurrent brief depression

851

Neuropsychological functioning following bilateral subthalamic nucleus stimulation in Parkinson’s disease

852

Neuropsychological functioning in a subclinical obsessive-compulsive sample

853

Neuropsychological Functioning in Adolescent Children of Mothers with a History of Bipolar or Major Depressive Disorders

854

Neuropsychological functioning in adult insulin-dependent diabetes mellitus (IDDM) patients

855

Neuropsychological Functioning in Bipolar Disorder and Schizophrenia

856

Neuropsychological functioning in chronic lyme disease: The role of mental effort

857

Neuropsychological Functioning in Danish Gulf War Veterans

858

Neuropsychological functioning in depressed adolescent girls

859

Neuropsychological functioning in kleptomania

860

Neuropsychological functioning in major depression and responsiveness to selective serotonin reuptake inhibitors antidepressants

861

Neuropsychological Functioning in Migraine Headache, Nonheadache Chronic Pain, and Mild Traumatic Brain Injury Patients

862

Neuropsychological Functioning in Obsessive-Compulsive Washers: Drug-Naive Without Depressive Symptoms

863

Neuropsychological functioning in people with ADHD across the lifespan

864

Neuropsychological functioning in sons of active alcoholic, recovering alcoholic, and social drinking fathers

865

Neuropsychological functioning in trichotillomania

866

Neuropsychological functioning in two brothers with X-linked adrenoleukodystrophy: A longitudinal case study of phenotypic variation and bone marrow transplant outcome

867

Neuropsychological Functioning in Youth with Bipolar Disorder

868

Neuropsychological functioning of children and adolescents with conduct disorder and aggressive-assaultive features

869

Neuropsychological functioning of dementia patients with psychosis

870

Neuropsychological Functioning of Inmates Referred for Psychiatric Treatment

871

Neuropsychological Functioning: Comparison of Mothers at High- and Low-Risk for Child Physical Abuse

872

Neuropsychological functions and the BASC

873

Neuropsychological functions in anxiety disorders in population-based samples: evidence of episodic memory dysfunction

874

Neuropsychological impairment after hemorrhagic stroke in basal ganglia

875

Neuropsychological impairment associated with compulsive hoarding

876

Neuropsychological impairment in fibromyalgia: Relation to depression, fatigue, and pain

877

Neuropsychological information in the Wechsler adult intelligence scale—revised

878

Neuropsychological Interventions: Clinical Practice and Research: By Paul J. Eslinger. New York: The Guilford Press, 2002, 359 pages

879

Neuropsychological Manifestation in Ebola: A Concern

880

Neuropsychological measures probably facilitate heritability research of ADHD

881

Neuropsychological outcome and quantitative neuroimaging in mild head injury,

882

Neuropsychological Outcome and the Extent of Resection in the Unilateral Temporal Lobectomy

883

Neuropsychological outcome following focal cortical removal for intractable epilepsy in children

884

Neuropsychological Outcome following Resuscitation after Out-of-Hospital Cardiac Arrest: A One-Year Follow-Up

885

Neuropsychological Outcome in Children after Frontal Lobe Epilepsy Surgery

886

Neuropsychological Outcome of Head Injury Using a Short Battery

887

NEUROPSYCHOLOGICAL OUTCOMES OF NOCTURNAL ASTHMA

888

Neuropsychological outcomes of pediatric burn patients who sustained hypoxic episodes

889

Neuropsychological parameters of pediatric migraineurs and tensioneurs

890

Neuropsychological performance deficits in adults with attention deficit/hyperactivity disorder

891

Neuropsychological performance in a sample of 13–25 year olds with a history of non-psychotic major depressive disorder

892

Neuropsychological performance in adult attention-deficit hyperactivity disorder: Meta-analysis of empirical data

893

Neuropsychological performance in bipolar I, bipolar II and unipolar depression patients: A longitudinal, naturalistic study

894

Neuropsychological Performance in Children and Adolescents with Obsessive-Compulsive Disorder and Influence of Clinical Variables

895

Neuropsychological Performance in First-Episode Adolescents with Schizophrenia: A Comparison with First-Episode Adults and Adolescent Control Subjects

896

Neuropsychological performance in gravesʹ hyperthyroidism: Evidence for executive dysfunction

897

Neuropsychological Performance in Gulf War Era Veterans: Motivational Factors and Effort

898

Neuropsychological Performance in Gulf War Era Veterans: Neuropsychological Symptom Reporting

899

Neuropsychological Performance in Gulf War Era Veterans: Traumatic Stress Symptomatology and Exposure to Chemical–Biological Warfare Agents

900

Neuropsychological performance in men and women at risk for hypertension

901

Neuropsychological performance in normal pregnancy and preeclampsia

902

Neuropsychological performance in pediatric bipolar disorder

903

Neuropsychological performance in schizotypal personality disorder: evidence regarding diagnostic specificity

904

Neuropsychological performance of a clinical sample of extremely obese individuals

905

Neuropsychological Performance of Adults Evidencing Attention-Deficit Hyperactivity Disorder

906

Neuropsychological performance of monozygotic twins discordant for bipolar disorder

907

Neuropsychological Performance Over Time in People at High Risk of Developing Schizophrenia and Controls

908

Neuropsychological performance predicts clinical recovery in bipolar patients

909

Neuropsychological predictors of adaptive living and work behaviors

910

Neuropsychological predictors of emotional prosody: Implications for hemispheric asymmetry

911

Neuropsychological Profile at Three Months Post Injury in Patients with Traumatic Brain Injury

912

Neuropsychological profile in patients with obsessive-compulsive disorder over a period of 4-month treatment

913

Neuropsychological Profile of a Large Kindred with Familial Alzheimerʹs Disease Caused by the E280A Single Presenilin-1 Mutation

914

Neuropsychological profile of patients with juvenile myoclonic epilepsy: A controlled study of 50 patients

915

Neuropsychological profile of prodromal Alzheimerʹs disease (Prd-AD) and their radiological correlates

916

Neuropsychological Profiles Associated with Subcortical White Matter Alterations and Parkinsonʹs Disease:: Implications for the Diagnosis of Dementia

917

Neuropsychological profiles of children diagnosed as specific language impaired with and without hyperlexia

918

Neuropsychological recovery from childhood moyamoya disease

919

Neuropsychological Sequelae in a Series of Patients with End-Stage Cystic Fibrosis: Lung Transplant Evaluation

920

Neuropsychological sequelae in subacute home chlordane poisoning: Ten case studies

921

Neuropsychological Similarities and Differences Among Huntington’s Disease, Multiple Sclerosis, and Cortical Dementia

922

Neuropsychological Studies of Late Onset and Subthreshold Diagnoses of Adult Attention-Deficit/Hyperactivity Disorder

923

Neuropsychological study of ciguatera fish poisoning: A longitudinal case-control study

924

Neuropsychological Test Development and Normative Data on Hispanics

925

Neuropsychological test performance and prediction of functional capacities among Spanish-speaking and English-speaking patients with dementia

926

Neuropsychological test performance in a cognitively intact sample of older Japanese American adults

927

Neuropsychological Test Performance in Illiterate Subjects

928

Neuropsychological test performance of children with ADHD relative to test norms and parent behavioral ratings

929

Neuropsychological Test Performances of Young Depressed Outpatient Women: An Examination of Executive Functions

930

Neuropsychological testing defines the neurobehavioral significance of neuroimaging-identified abnormalities

931

Neuropsychological testing of adults: further considerations for neurologists

932

Neuropsychological testing of high school athletes: Preliminary norms and test–retest indices

933

Neuropsychological tests and SPECT in dementing disorders

934

Neuropsychological tests predict independent activities of daily living in patients with dementia

935

Neuropsychological toxicology: Identification and assessment of human neurotoxic syndromes : Second Edition, by David E. Hartman. New York: Plenum Press, 1995. 429 pp, $59.50 hardcover

936

Neuropsychological, Neuroanatomical, and Neurophysiological Consequences of CNS Chemotherapy for Acute Lymphoblastic Leukemia

937

Neuropsychological, olfactory, and hygiene deficits in men with negative symptom schizophrenia

938

Neuropsychologistsʹ Practice Patterns in Assessing Premorbid Intelligence

939

Neuropsychologists’ abilities to determine the predictive value of diagnostic tests

940

Neuropsychology and linguistic aphasiology: Evidence in favor of case studies

941

Neuropsychology is nothing without control: A potential fallacy hidden in clinical studies

942

Neuropsychology of Alzheimerʹs Disease

943

Neuropsychology of bipolar disorder: a review

944

Neuropsychology of BPI and BPII

945

Neuropsychology of BPI and BPII

946

Neuropsychology of BPI and BPII

947

Neuropsychology of developmental stuttering

948

Neuropsychology of dual diagnosis: Understanding the combined effects of schizophrenia and substance use disorders

949

Neuropsychology of obsessive-compulsive disorder: a review and treatment implications

950

Neuropsychology of timing and time perception

951

Neuropsychology, the Patientʹs Experience, and the Political Forces Within Our Field

952

Neuroptera in agricultural ecosystems

953

Neuropteran (Insecta) palaeodiversity with predictions for the Cretaceous fauna of the Wealden

954

Neuroradiologic MR applications with multiparametric color composite display

955

Neuroradiological assessment of brain structure and function and its implication in the pathogenesis of West syndrome

956

Neuroradiological findings in primary cerebral lymphomas of non-AIDS patients

957

Neuroradiology of spine degenerative diseases

958

Neuroreceptor subunit genes and the genetic susceptibility to gilles de la tourette syndrome

959

Neurorehabilitation, the Practical Method of Returning to Work after Stroke

960

Neurorehabilitation: no more constraint for large randomised trials

961

Neuroretinal function is normal in early dementia of the Alzheimer type

962

Neurosarcoidosis

963

Neurosarcoidosis presenting as a large suprasellar mass: Magnetic resonance imaging findings

964

Neurosarcoidosis presenting with simple partial seizures and solitary enhancing mass: case reports and review of the literature

965

Neurosarcoidosis: a clinical dilemma

966

Neurosarcoidosis: a treatable cause of vestibular dysfunction

967

Neurosarcoidosis: Findings in MRI

968

Neuroscience and computing algorithms

969

Neuroscience and the soul: Competing explanations for the human experience

970

Neuroscience approach in Stem cell therapy among patients with Spinal Cord Injury

971

Neuroscience as an Insightful Decision Support Tool for Sustainable Development

972

Neuroscience meets dance/movement therapy: Mirror neurons, the therapeutic process and empathy

973

Neuroscience output of China: A MEDLINE-based bibliometric study

974

Neuroscience research on the addictions: A prospectus for future ethical and policy analysis

975

Neuroscience, neuroimaging and the law

976

Neuroscience, quantum indeterminism and the Cartesian soul

977

Neuroscience: Where is it heading?: Some reflections on the future of brain research at the end of the second millenium

978

Neuroscience-Informed Psychoeducation for Recovery: A Program to Promote Metacognition in People With Substance Use Disorders

979

Neurosciences Quiz: Subclinical rhythmic electrographic discharges of adults (SREDA): Case Presentation

980

Neurosciences, psychiatrie et psychopathologie : quelles évolutions pour la relation clinique ?

981

Neuroscientific challenges to free will and responsibility

982

Neuroscientists discover disgusting regions of the brain

983

Neuroscientists hear impassioned plea from Superman

984

Neuroscientists take a BOLD step forward

985

Neuro-Second Order Sliding Mode Control of a DFIG Supplied by a Two-Level NSVM Inverter for Wind Turbine System

986

Neurosensory changes of palatal mucousa following Le Fort I osteotomy

987

Neuro-short-term load forecast of the power system in Kuwait

988

Neuro-simulation analysis of pressure maintenance operations in gas condensate reservoirs

989

Neuro-simulation modeling of chemical flooding

990

Neurosolver: Neuromorphic general problem solver

991

Neurosphere-Free Transdifferentiation of Rat Bone Marrow Stromal Stem Cells Into Retinal Cells and Retinal Pigment Epithelium

992

Neurospora crassa CyPBP37: A Cytosolic Stress Protein that is able to Replace Yeast Thi4p Function in the Synthesis of Vitamin B1

993

Neurospora crassa FKBP22 Is a Novel ER Chaperone and Functionally Cooperates with BiP

994

Neurosteroid analogues. Part 13: Synthetic methods for the preparation of 2β-hydroxygonane derivatives as structural mimics of ent-3α-hydroxysteroid modulators of GABAA receptors

995

Neurosteroid analogues: synthesis of 6-aza-allopregnanolone

996

Neurosteroid analysis by gas chromatography–atmospheric pressure photoionization–tandem mass spectrometry Original Research Article

997

Neurosteroid dehydroepiandrosterone attenuates 6-hydroxydopamine-induced apoptosis in a cell model of Parkinson's disease

998

Neurosteroids in Rat Brain: Extraction, Isolation, and Analysis by Nanoscale Liquid Chromatography-Electrospray Mass Spectrometry

999

Neurosteroids: 7-aza-allopregnanolone—a poor substitute for allopregnanolone

1000

Neurostimulation as a Putative Method for the Treatment of Drug-resistant Epilepsy in Patient and Animal Models of Epilepsy

بازگشت